Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
These may include a 24-hour liquid diet, gastric ultrasound, or procedure delay
Injectable semaglutide and tirzepatide trials have shown average weight loss ranging from approximately 15% to 22% in different populations
This is an injectable product intended strictly for licensed medical professionals
Because every body responds differently, your provider will monitor your progress and adjust your plan as needed
The SUSTAIN-7 trial directly compared dulaglutide with semaglutide, showing differences in gastrointestinal tolerability
Methionine has small studies to show that it can improve metabolic disorders (such as diabetes, steatosis, and insulin resistance), decrease inflammation, and improve bone health 2
US$ 27.62
US$ 23.91
US$ 21.63
US$ 27.22
US$ 22.02
